Tempest Therapeutics Inc [TPST] stock prices are up 8.54% to $8.95 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The TPST shares have gain 33.58% over the last week, with a monthly amount glided 30.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tempest Therapeutics Inc [NASDAQ: TPST] stock has seen the most recent analyst activity on April 10, 2025, when Scotiabank downgraded its rating to a Sector Perform. Previously, H.C. Wainwright downgraded its rating to Neutral on April 10, 2025. On March 14, 2024, Scotiabank initiated with a Sector Outperform rating and assigned a price target of $13 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $15 on February 08, 2024.
The stock price of Tempest Therapeutics Inc [TPST] has been fluctuating between $5.35 and $42.12 over the past year. Tempest Therapeutics Inc [NASDAQ: TPST] shares were valued at $8.95 at the most recent close of the market.
Analyzing the TPST fundamentals
Gross Profit Margin for this corporation currently stands at 0.18% with Operating Profit Margin at -92.57%, Pretax Profit Margin comes in at -92.18%, and Net Profit Margin reading is -92.18%. To continue investigating profitability, this company’s Return on Assets is posted at -1.39, Equity is -3.06 and Total Capital is -2.37. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.80 points at the first support level, and at 6.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.02, and for the 2nd resistance point, it is at 13.10.
Ratios To Look Out For
It’s worth pointing out that Tempest Therapeutics Inc [NASDAQ:TPST]’s Current Ratio is 1.70. On the other hand, the Quick Ratio is 1.70, and the Cash Ratio is 1.63.
Transactions by insiders
Recent insider trading involved Versant Venture Capital VI, L., Owner, that happened on Aug 12 ’24 when 0.39 million shares were purchased. 10% Owner, Versant Venture Capital VI, L. completed a deal on Aug 08 ’24 to sell 0.4 million shares. Meanwhile, 10% Owner Versant Venture Capital VI, L. sold 0.39 million shares on Aug 12 ’24.
